Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05807256 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 18, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2024 to Oct 30, 2025
    • Study completion date: Dec 31, 2025 to Nov 30, 2025
    v3
  2. Primary completion date: Dec 31, 2023 to Dec 31, 2024
    • Study completion date: Dec 31, 2023 to Dec 31, 2025
    • Study description expanded, about 200 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Systemic rheumatological diseases often occur in young women of childbearing age and can therefore impact fertility. There are diseases, such as arthritis, which present no contraindication to assisted reproductive techniques (ARTs), because there is no influence on the disease itself if the disease activity at conception is stable. On the other hand, patients suffering from connective tissue diseases, primarily Systemic Lupus Erythematosus (SLE) and patients suffering from primary or SLE-related Anti-Phospholipid Antibody Syndrome (APS), deserve more targeted therapies both in the context of ARTs and in the ensuing pregnancy. To evaluate the response to ARTs in patients with systemic rheumatological diseases, both in terms of reactivation of the underlying pathology and in terms of ARTs outcome.
Trial Details
NCT Number NCT05807256
Lead Sponsor IRCCS San Raffaele
Conditions
(from sponsor)		 Rheumatic Diseases, Fertility Disorders, Pregnancy, High Risk, Pregnancy Complications, Immunologic Disease
Related terms Immune System Diseases, Pregnancy Complications, Rheumatic Diseases
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov